Table 10-A
Single-year Cancer Incidence by Stage at Diagnosis
Michigan Residents, 1985-2020

Year of Diagnosis	Total	In Situ		Localized		Regional		Distant		Unknown
		Number	Percent	Number	Percent	Number	Percent	Number	Percent	Number	Percent
2020	59,292	8,511	14.4	23,381	39.4	10,741	18.1	13,043	22.0	3,616	6.1
2019	65,304	9,108	13.9	25,738	39.4	12,026	18.4	13,923	21.3	4,509	6.9
2018	63,975	8,272	12.9	25,833	40.4	11,835	18.5	14,090	22.0	3,945	6.2
2017	63,328	8,463	13.4	24,461	38.6	11,783	18.6	13,604	21.5	5,017	7.9
2016	64,274	8,669	13.5	24,712	38.4	11,956	18.6	14,077	21.9	4,860	7.6
2015	62,330	8,385	13.5	23,613	37.9	11,207	18.0	14,317	23.0	4,808	7.7
2014	60,613	7,986	13.2	22,751	37.5	11,005	18.2	13,953	23.0	4,918	8.1
2013	59,595	7,269	12.2	23,311	39.1	11,177	18.8	13,918	23.4	3,920	6.6
2012	60,701	7,988	13.2	23,608	38.9	11,327	18.7	13,792	22.7	3,986	6.6
2011	62,818	8,249	13.1	25,235	40.2	11,458	18.2	14,035	22.3	3,841	6.1
2010	62,193	8,240	13.2	24,366	39.2	11,097	17.8	14,079	22.6	4,411	7.1
2009	61,515	8,639	14.0	24,717	40.2	10,692	17.4	12,824	20.8	4,643	7.5
2008	60,483	8,054	13.3	23,948	39.6	10,447	17.3	12,456	20.6	5,578	9.2
2007	62,379	7,806	12.5	25,098	40.2	10,565	16.9	13,184	21.1	5,726	9.2
2006	60,040	7,680	12.8	23,239	38.7	10,463	17.4	12,539	20.9	6,119	10.2
2005	59,475	7,948	13.4	22,655	38.1	10,010	16.8	12,038	20.2	6,824	11.5
2004	58,643	7,648	13.0	22,067	37.6	9,803	16.7	10,666	18.2	8,459	14.4
2003	59,878	7,821	13.1	22,858	38.2	10,085	16.8	11,170	18.7	7,944	13.3
2002	59,920	8,264	13.8	23,697	39.5	10,354	17.3	10,855	18.1	6,750	11.3
2001	58,585	7,897	13.5	23,026	39.3	9,890	16.9	10,490	17.9	7,282	12.4
2000	57,836	7,571	13.1	23,091	39.9	9,863	17.1	9,779	16.9	7,532	13.0
1999	56,862	7,061	12.4	23,053	40.5	9,856	17.3	9,388	16.5	7,504	13.2
1998	55,370	6,818	12.3	21,618	39.0	9,795	17.7	9,739	17.6	7,400	13.4
1997	53,967	6,339	11.7	20,989	38.9	9,603	17.8	9,819	18.2	7,217	13.4
1996	52,642	6,239	11.9	20,424	38.8	9,361	17.8	9,420	17.9	7,198	13.7
1995	51,505	5,884	11.4	19,167	37.2	9,333	18.1	8,955	17.4	8,166	15.9
1994	51,432	5,395	10.5	19,114	37.2	9,327	18.1	8,915	17.3	8,681	16.9
1993	52,661	5,225	9.9	19,766	37.5	9,586	18.2	9,298	17.7	8,786	16.7
1992	53,476	5,001	9.4	20,477	38.3	9,708	18.2	9,336	17.5	8,954	16.7
1991	52,593	4,977	9.5	19,019	36.2	9,330	17.7	9,272	17.6	9,995	19.0
1990	49,013	4,730	9.7	16,601	33.9	8,943	18.2	8,917	18.2	9,822	20.0
1989	46,591	4,126	8.9	14,919	32.0	8,664	18.6	8,900	19.1	9,982	21.4
1988	42,837	3,778	8.8	14,404	33.6	8,734	20.4	8,621	20.1	7,300	17.0
1987	42,137	3,722	8.8	14,063	33.4	7,458	17.7	8,377	19.9	8,517	20.2
1986	39,967	3,292	8.2	13,388	33.5	7,506	18.8	8,319	20.8	7,462	18.7
1985	39,495	3,114	7.9	13,640	34.5	7,481	18.9	8,277	21.0	6,983	17.7

Table 10-B
Five-year Cancer Incidence by Stage at Diagnosis
Michigan Residents, 1985-2020

Year of Diagnosis	Total	In Situ		Localized		Regional		Distant		Unknown
		Number	Percent	Number	Percent	Number	Percent	Number	Percent	Number	Percent
2016-2020	316,173	43,023	13.6	124,125	39.3	58,341	18.5	68,737	21.7	21,947	6.9
2015-2019	319,211	42,897	13.4	124,357	39.0	58,807	18.4	70,011	21.9	23,139	7.2
2014-2018	314,520	41,775	13.3	121,370	38.6	57,786	18.4	70,041	22.3	23,548	7.5
2013-2017	310,140	40,772	13.1	118,848	38.3	57,128	18.4	69,869	22.5	23,523	7.6
2012-2016	307,513	40,297	13.1	117,995	38.4	56,672	18.4	70,057	22.8	22,492	7.3
2011-2015	306,057	39,877	13.0	118,518	38.7	56,174	18.4	70,015	22.9	21,473	7.0
2010-2014	305,920	39,732	13.0	119,271	39.0	56,064	18.3	69,777	22.8	21,076	6.9
2009-2013	306,822	40,385	13.2	121,237	39.5	55,751	18.2	68,648	22.4	20,801	6.8
2008-2012	307,710	41,170	13.4	121,874	39.6	55,021	17.9	67,186	21.8	22,459	7.3
2007-2011	309,388	40,988	13.2	123,364	39.9	54,259	17.5	66,578	21.5	24,199	7.8
2006-2010	306,610	40,419	13.2	121,368	39.6	53,264	17.4	65,082	21.2	26,477	8.6
2005-2009	303,892	40,127	13.2	119,657	39.4	52,177	17.2	63,041	20.7	28,890	9.5
2004-2008	301,020	39,136	13.0	117,007	38.9	51,288	17.0	60,883	20.2	32,706	10.9
2003-2007	300,415	38,903	12.9	115,917	38.6	50,926	17.0	59,597	19.8	35,072	11.7
2002-2006	297,956	39,361	13.2	114,516	38.4	50,715	17.0	57,268	19.2	36,096	12.1
2001-2005	296,501	39,578	13.3	114,303	38.6	50,142	16.9	55,219	18.6	37,259	12.6
2000-2004	294,862	39,201	13.3	114,739	38.9	49,995	17.0	52,960	18.0	37,967	12.9
1999-2003	293,081	38,614	13.2	115,725	39.5	50,048	17.1	51,682	17.6	37,012	12.6
1998-2002	288,573	37,611	13.0	114,485	39.7	49,758	17.2	50,251	17.4	36,468	12.6
1997-2001	282,620	35,686	12.6	111,777	39.6	49,007	17.3	49,215	17.4	36,935	13.1
1996-2000	276,677	34,028	12.3	109,175	39.5	48,478	17.5	48,145	17.4	36,851	13.3
1995-1999	270,346	32,341	12.0	105,251	38.9	47,948	17.7	47,321	17.5	37,485	13.9
1994-1998	264,916	30,675	11.6	101,312	38.2	47,419	17.9	46,848	17.7	38,662	14.6
1993-1997	262,207	29,082	11.1	99,460	37.9	47,210	18.0	46,407	17.7	40,048	15.3
1992-1996	261,716	27,744	10.6	98,948	37.8	47,315	18.1	45,924	17.5	41,785	16.0
1991-1995	261,667	26,482	10.1	97,543	37.3	47,284	18.1	45,776	17.5	44,582	17.0
1990-1994	259,175	25,328	9.8	94,977	36.6	46,894	18.1	45,738	17.6	46,238	17.8
1989-1993	254,334	24,059	9.5	90,782	35.7	46,231	18.2	45,723	18.0	47,539	18.7
1988-1992	244,510	22,612	9.2	85,420	34.9	45,379	18.6	45,046	18.4	46,053	18.8
1987-1991	233,171	21,333	9.1	79,006	33.9	43,129	18.5	44,087	18.9	45,616	19.6
1986-1990	220,545	19,648	8.9	73,375	33.3	41,305	18.7	43,134	19.6	43,083	19.5
1985-1989	211,027	18,032	8.5	70,414	33.4	39,843	18.9	42,494	20.1	40,244	19.1

Notes:
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion.
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel.
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes.
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes.
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends.
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services.
Last Updated : April 13, 2023